Initial Submission Co-Ezetimibe TEVA 10 mg/20 mg Reg No. 2C 15059/63 (NG) Approval date 25 May 2020 Register s
![EZETIMIBE AND SIMVASTATIN TABLETS These highlights do not include all the information needed to use EZETIMIBE AND SIMVASTATIN TABLETS safely and effectively. See full prescribing information for EZETIMIBE AND SIMVASTATIN TABLETS . EZETIMIBE AND SIMVASTATIN TABLETS These highlights do not include all the information needed to use EZETIMIBE AND SIMVASTATIN TABLETS safely and effectively. See full prescribing information for EZETIMIBE AND SIMVASTATIN TABLETS .](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=60429-881-30LB.jpg&id=572058)
EZETIMIBE AND SIMVASTATIN TABLETS These highlights do not include all the information needed to use EZETIMIBE AND SIMVASTATIN TABLETS safely and effectively. See full prescribing information for EZETIMIBE AND SIMVASTATIN TABLETS .
![NHS England considering three models to make high-dose statins available in community pharmacy - The Pharmaceutical Journal NHS England considering three models to make high-dose statins available in community pharmacy - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2021/07/atorvastatin-927x617.jpg)
NHS England considering three models to make high-dose statins available in community pharmacy - The Pharmaceutical Journal
![Close up Blister Pack Ezetimibe NHS prescription tablets lipid lowering to reduce high cholesterol Stock Photo - Alamy Close up Blister Pack Ezetimibe NHS prescription tablets lipid lowering to reduce high cholesterol Stock Photo - Alamy](https://c8.alamy.com/comp/D2WXYR/close-up-blister-pack-ezetimibe-nhs-prescription-tablets-lipid-lowering-D2WXYR.jpg)